Assignee
ABCLON INC
KR·8 granted patents·3 pending applications·7 citations·filing 2014–2023
Top patents by PatentIndex Score
11 records- 0179US10174116B2Antibody specifically binding to HER2ABCLON INC·Filed 2014·Granted Jan 8, 2019·7 cites·32 claims
- 0272US12090171B2Antibody or antigen binding fragment thereof for specifically recognizing B cell malignancy, chimeric antigen receptor comprising same and use thereofABCLON INC·Filed 2022·Granted Sep 17, 2024·0 cites·14 claims
- 0367US2025188195A1Antibody or antigen-binding fragment thereof that targets cotinine, chimeric antigen receptor comprising same, and uses thereofABCLON INC·Filed 2023·Application pending·0 cites
- 0464US12414998B2Anti-HER2 affibody and switchable chimeric antigen receptor using same as switch moleculeABCLON INC·Filed 2021·Granted Sep 16, 2025·0 cites·10 claims
- 0564US2024392023A1Anti-cd30 antibody and chimeric antigen receptor comprising thereofABCLON INC·Filed 2023·Application pending·0 cites
- 0653US10465008B2Antibodies against vascular endothelial growth factor receptor 2 (VEGFR2), encoding nucleic acid molecules and methods for treating an angiogenesis-related diseaseABCLON INC·Filed 2016·Granted Nov 5, 2019·0 cites·19 claims
- 0752US11534462B2Antibody or antigen binding fragment thereof for specifically recognizing B cell malignancy, chimeric antigen receptor comprising same and use thereofABCLON INC·Filed 2018·Granted Dec 27, 2022·0 cites·8 claims
- 0851US11708409B2Antibody or antigen-binding fragment thereof that specifically recognizes B cell malignancies, chimeric antigen receptor comprising same, and uses thereofABCLON INC·Filed 2018·Granted Jul 25, 2023·0 cites·9 claims
- 0951US11248059B2Antibody having improved stability and specifically binding to HER2ABCLON INC·Filed 2017·Granted Feb 15, 2022·0 cites·4 claims
- 1044US11945878B2Switch molecule and switchable chimeric antigen receptorABCLON INC·Filed 2019·Granted Apr 2, 2024·0 cites·2 claims
- 1144US2021122816A1Polypeptide improved in protein purity and affinity for antigen, conjugate thereof with antibody or antigen-binding fragment, and preparation method thereforABCLON INC·Filed 2018·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →